Search

Your search keyword '"Varela, A. Mera"' showing total 13 results
Start Over Author "Varela, A. Mera"
13 results on '"Varela, A. Mera"'

1. SAT0063 ASSOCIATION OF SMOKING WITH TRIPLE CONCORDANT SEROPOSITIVITY IN RA PATIENTS, AND WITH RHEUMATOID FACTOR IN THE REMAINING PATIENTS

Author

Regueiro, Cristina, primary, Rodriguez, Luis Rodriguez, additional, López-Mejías, Raquel, additional, Nuño, Laura, additional, Triguero-Martinez, Ana, additional, Perez-Pampín, Eva, additional, Corrales, Alfonso, additional, Villalva, Alejandro, additional, Lopez-Golan, Yolanda, additional, Abasolo, Lydia, additional, Martinez, Sara Remuzgo, additional, Ortiz, Ana, additional, Herranz, Eva, additional, Martínez-Feito, Ana, additional, Conde, Carmen, additional, Varela, Antonio Mera, additional, Balsa, Alejandro, additional, González-Álvaro, Isidoro, additional, González-Gay, Miguel A., additional, Fernandez, Benjamin, additional, and Gonzalez, Antonio, additional

Published
2019
Full Text
View/download PDF

3. THU0313 COMPARATIVE STUDY OF CLINICAL, ANALYTICAL AND VASCULAR 18F-FDG UPTAKE EVOLUTION IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH METHOTREXATE VS TOCILIZUMAB

Author

Prieto-Peña, D., primary, Calderón-Goercke, Monica, additional, Loricera, Javier, additional, Narváez, J., additional, Aurrecoechea, Elena, additional, Villa-Blanco, Ignacio, additional, Castañeda, Santos, additional, Gomez-Arango, Catalina, additional, Varela, Antonio Mera, additional, Perez-Pampín, Eva, additional, Aldasoro, Vicente, additional, Alvarez-Rivas, Noelia, additional, Fernández-Llanio, Nagore, additional, Buergo, María Álvarez del, additional, Rojas, Luisa Marena, additional, Sivera, Francisca, additional, Galindez, Eva, additional, Solans-Laqué, Roser, additional, Romero-Yuste, Susana, additional, Martínez-Rodríguez, Isabel, additional, Banzo, Jose Ignacio, additional, González-Gay, Miguel A, additional, and Blanco, Ricardo, additional

Published
2019
Full Text
View/download PDF

4. OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL

Author

Baraliakos, Xenofon, primary, Coates, Laura C, additional, Gossec, Laure, additional, Jeka, Sławomir, additional, Varela, Antonio Mera, additional, Schulz, Barbara, additional, Rissler, Michael, additional, Gupta, Ayan Das, additional, Perella, Chiara, additional, and Pournara, Effie, additional

Published
2019
Full Text
View/download PDF

6. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.

Author

Pablos, Jose L., Abasolo, Lydia, Alvaro-Gracia, Jose M., Blanco, Francisco J., Blanco, Ricardo, Castrejón, Isabel, Fernandez-Fernandez, David, Fernandez-Gutierrez, Benjamín, Galindo-Izquierdo, María, Gonzalez-Gay, Miguel A., Manrique-Arija, Sara, Mena Vázquez, Natalia, Varela, Antonio Mera, Retuerto, Miriam, Seijas-Lopez, Alvaro, Mera Varela, Antonio, and RIER investigators group

Subjects
DRUG therapy for rheumatism, VIRAL pneumonia, RESEARCH, RESEARCH methodology, AUTOIMMUNE diseases, COVID-19, RETROSPECTIVE studies, EVALUATION research, MEDICAL cooperation, ANTIRHEUMATIC agents, COMPARATIVE studies, HOSPITAL care, RHEUMATOID arthritis, DISEASE prevalence, EPIDEMICS, RHEUMATISM, SYSTEMIC lupus erythematosus, DEMOGRAPHY, POLYMERASE chain reaction
Abstract

Background: The susceptibility of patients with rheumatic diseases and the risks or benefits of immunosuppressive therapies for COVID-19 are unknown.Methods: We performed a retrospective study with patients under follow-up in rheumatology departments from seven hospitals in Spain. We matched updated databases of rheumatology patients with severe acute respiratory syndrome coronavirus 2-positive PCR tests performed in the hospital to the same reference populations. Rates of PCR+ confirmed COVID-19 were compared among groups.Results: Patients with chronic inflammatory diseases had 1.32-fold higher prevalence of hospital PCR+ COVID-19 than the reference population (0.76% vs 0.58%). Patients with systemic autoimmune or immune-mediated disease (AI/IMID) showed a significant increase, whereas patients with inflammatory arthritis (IA) or systemic lupus erythematosus did not. COVID-19 cases in some but not all diagnostic groups had older ages than cases in the reference population. Patients with IA on targeted-synthetic or biological disease-modifying antirheumatic drugs (DMARDs), but not those on conventional-synthetic DMARDs, had a greater prevalence despite a similar age distribution.Conclusion: Patients with AI/IMID show a variable risk of hospital-diagnosed COVID-19. Interplay of ageing, therapies and disease-specific factors seem to contribute. These data provide a basis to improve preventive recommendations to rheumatic patients and to analyse the specific factors involved in COVID-19 susceptibility. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

8. DNA-METHYLATION PROFILING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE.

Author

Kaczmarczyk, B., De la Calle-Fabregat, C., Duarte, A. C., Mena-Vázquez, N., Fernandez-Nebro, A., Triguero-Martinez, A., Castañeda, S., Dos-Santos, R., Varela, A. Mera, Lopez-Pedrera, C., Contreras, A. Escudero, Vela-Casasempere, P., Molina, M. Molina, Narváez, J., Retuerto-Guerrero, M., Pablos, J. L., Sarmiento-Monroy, J. C., Sanmartí, R., Carrera, L. Gómez, and Bonilla, G.

Published
2023
Full Text
View/download PDF

12. Infection by Mycobacterium chelonae at the site of administration of sarilumab for rheumatoid arthritis.

Author

Sobrín, Raquel Dos Santos, Gómez, Nair Pérez, Vilas, Alejandro Souto, Suárez, Manuel Pombo, Pampín, Eva Pérez, López, Jose Ramón Antúnez, and Varela, Antonio Mera

Subjects
AMOXICILLIN, ANTIRHEUMATIC agents, BIOPSY, CLAVULANIC acid, INJECTIONS, MONOCLONAL antibodies, MYCOBACTERIAL diseases, RHEUMATOID arthritis
Abstract

The article presents a case study of a 62-year-old female patient that developed Mycobacterium chelonae infection which may be attributed to her therapeutic use of sarilumab for rheumatoid arthritis. Topics discussed include the patient's use of sarilumab with low-dose glucocorticoids for five years, results of the skin biopsy and microbiological tests performed, and antibiotic therapy prescribed which resolved the patient's skin lesion.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results